Get alerts for new trials in your area by subscribing now
Active & Responsive
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
for
Ocular Hypertension, Suspect Glaucoma
Location: Baltimore MD, Columbia MD, Silver Spring MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT04401982
Recruiting
Active & Responsive
Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
for
Glaucoma
Location: Kansas City MO
Sponsor: Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Sex: All
Age: 18 - 65
Code: NCT07209410
Recruiting
Active & Responsive
A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
for
Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OH)
Location: Newport Beach CA
Sponsor: YS Life Science Co., Ltd.
Sex: All
Age: 18+
Code: NCT07661329
Phase3, Recruiting
New
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.
for
Glaucoma
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT07739784
Recruiting
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation